CD38 and obesity due to melanocortin 4 receptor deficiency: Inhibition of CD38 in obesity models led to an enhanced metabolic profile, increased NAD+ levels, and decreased protein acetylation, possibly due to enhanced SIRT1 activity due to higher NAD+ availability [160].